Kyverna Therapeutics appoints Marc Grasso as CFO

1 week ago 2

Kyverna Therapeutics (NASDAQ:KYTX) announced on Monday the appointment of Marc Grasso as its chief financial officer (CFO), effective today.
Most recently, Grasso served as CFO of Alector, a clinical-stage biotechnology company focused on neurodegenerative diseases, where he oversaw Financial Planning and Analysis, Investor Relations, Accounting, Information

Recommended For You